Commentary on ‘Pharmacotherapy for anxiety disorders in children and adolescents’ with a response from the review authors
✍ Scribed by David Cohen; Martine F. Flament; Angèle Consoli; Jonathan C. Ipser; Susan Hawkridge; Lara Hoppe; Dan J. Stein
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 69 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1557-6272
- DOI
- 10.1002/ebch.500
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
This is a commentary on a Cochrane review, published in this issue of EBCH, first published as: Ipser JC, Stein DJ, Hawkridge S, Hoppe L. Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD005170. DOI: 10.1002/14651858.CD005170.pub2.
Further information for this Cochrane review is available in this issue of EBCH in the accompanying Summary article. Copyright © 2010 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract This is a commentary on a Cochrane review, published in this issue of EBCH, first published as: Hetrick SE, Merry S, McKenzie J, Sindahl R, Protctor M. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. __Cochrane Database of Systematic
## Abstract This is a commentary on a Cochrane review, published in this issue of EBCH, first published as: O'Kearney RT, Anstey KJ, von Sanden C. Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents. __Cochrane Database of Systematic Reviews__